Associated Papers
Metabolic gene polymorphisms and type 2 diabetes mellitus risk: A systematic review and meta-analyses.
Indarto D et al.
Experimental and Therapeutic Medicine, 2026
Pharmacogenetics of incretin-based therapies.
Yaluri AS et al.
Postgraduate Medical Journal, 2025
Polygenic risk score and cluster-based analysis suggests links between type 2 diabetes and vascular dementia in the KARE study.
Dong W et al.
Nature Communications, 2025
Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice.
Tonin G et al.
Frontiers in Endocrinology, 2025
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma.
Patiño-García A et al.
Ebiomedicine, 2024
Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes.
Melchiorsen JU et al.
The Journal of Clinical Endocrinology and Metabolism, 2023
Rare Variants of Obesity-Associated Genes in Young Adults with Abdominal Obesity.
Bairqdar A et al.
Journal of Personalized Medicine, 2023
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials.
Dawed AY et al.
The Lancet. Diabetes & Endocrinology, 2023
Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis.
Vujkovic M et al.
Nature Genetics, 2020
Genetic variants associated with glycemic response to treatment with dipeptidylpeptidase 4 inhibitors.
Űrgeová A et al.
Pharmacogenomics, 2020
Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
Jensterle M et al.
European Journal of Clinical Pharmacology, 2015
Association of genetic variants of the incretin-related genes with quantitative traits and occurrence of type 2 diabetes in Japanese.
Enya M et al.
Molecular Genetics and Metabolism Reports, 2014
[Association between polymorphisms of TCF7L2 and type 2 diabetes with special reference to incretin action].
Enya M et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine, 2011
Five missense mutations in glucagon-like peptide 1 receptor gene in Japanese population.
Tokuyama Y et al.
Diabetes Research and Clinical Practice, 2004
A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain.
Tibaduiza EC et al.
The Journal of Biological Chemistry, 2001